Literature DB >> 17453614

High abstinence rates in heroin addicts by a new comprehensive treatment approach.

Cor A J De Jong1, Hendrik G Roozen, Leo G M van Rossum, Paul F M Krabbe, Ad J F M Kerkhof.   

Abstract

In this multi-center, naturalistic study, the effectiveness of naltrexone maintenance combined with the Community Reinforcement Approach (CRA) was investigated in detoxified, opioid-dependent patients (N=272). Patients were recruited from methadone maintenance programs. With intention-to-treat analysis, 10 months of treatment yielded abstinence rates of 28% and 32% at 10 and 16 months after detoxification. The cumulative abstinence rate at 16 months was 24%. Quality of life, craving, general psychopathology, use of other psychoactive substances, and addiction severity of the abstinent group significantly improved when compared to the relapsed group. This abstinence-oriented approach appears to be a feasible goal, and remains an important option next to long-term methadone maintenance in the management of opioid dependence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453614     DOI: 10.1080/10550490601184472

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  11 in total

1.  Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.

Authors:  Stephen T Tiffany; Lawrence Friedman; Shelly F Greenfield; Deborah S Hasin; Ron Jackson
Journal:  Addiction       Date:  2011-10-07       Impact factor: 6.526

2.  Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes.

Authors:  Jeffrey M Pyne; Shanti Tripathi; Michael French; Kathryn McCollister; Richard C Rapp; Brenda M Booth
Journal:  Addiction       Date:  2011-03       Impact factor: 6.526

3.  Interoceptive attention in opioid and stimulant use disorder.

Authors:  Jennifer L Stewart; Sahib S Khalsa; Rayus Kuplicki; Maria Puhl; Martin P Paulus
Journal:  Addict Biol       Date:  2019-10-16       Impact factor: 4.280

4.  Adolescent Community Reinforcement Approach implementation and treatment outcomes for youth with opioid problem use.

Authors:  Mark D Godley; Lora L Passetti; Geetha A Subramaniam; Rodney R Funk; Jane Ellen Smith; Robert J Meyers
Journal:  Drug Alcohol Depend       Date:  2017-02-22       Impact factor: 4.492

5.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

6.  The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.

Authors:  Eugenia Oviedo-Joekes; Kirsten Marchand; Kurt Lock; Scott MacDonald; Daphne Guh; Martin T Schechter
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-01-26

7.  A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.

Authors:  Eugenia Oviedo-Joekes; Kirsten Marchand; Kurt Lock; Jill Chettiar; David C Marsh; Suzanne Brissette; Aslam H Anis; Martin T Schechter
Journal:  Addict Sci Clin Pract       Date:  2014-09-29

8.  Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder.

Authors:  Eugenia Oviedo-Joekes; Heather Palis; Daphne Guh; David C Marsh; Scott MacDonald; Scott Harrison; Suzanne Brissette; Aslam H Anis; Martin T Schechter
Journal:  J Addict Med       Date:  2019 Sep/Oct       Impact factor: 3.702

Review 9.  The community reinforcement approach: an update of the evidence.

Authors:  Robert J Meyers; Hendrik G Roozen; Jane Ellen Smith
Journal:  Alcohol Res Health       Date:  2011

10.  The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users.

Authors:  Kirsten Marchand; Heather Palis; Defen Peng; Jill Fikowski; Scott Harrison; Patricia Spittal; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  J Addict Med       Date:  2015 Sep-Oct       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.